calpain inhibitor 2 has been researched along with naphthoquinones in 2 studies
Studies (calpain inhibitor 2) | Trials (calpain inhibitor 2) | Recent Studies (post-2010) (calpain inhibitor 2) | Studies (naphthoquinones) | Trials (naphthoquinones) | Recent Studies (post-2010) (naphthoquinones) |
---|---|---|---|---|---|
68 | 0 | 13 | 7,110 | 149 | 2,923 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Qian, W; Shichi, H | 1 |
Chau, GY; Chau, YP; Chien, CL; Don, MJ; Kung, HN; Lu, KS | 1 |
2 other study(ies) available for calpain inhibitor 2 and naphthoquinones
Article | Year |
---|---|
Naphthoquinone-Induced cataract in mice: possible involvement of Ca2+ release and calpain activation.
Topics: Animals; Anterior Chamber; Calcium; Calpain; Cataract; Epithelial Cells; Glycoproteins; Lens, Crystalline; Male; Mice; Mice, Inbred C57BL; Microscopy, Confocal; Naphthoquinones; Oligopeptides | 2001 |
Involvement of NO/cGMP signaling in the apoptotic and anti-angiogenic effects of beta-lapachone on endothelial cells in vitro.
Topics: Angiogenesis Inhibitors; Apoptosis; Arginine; Calcium; Calpain; Caspases; Cell Line; Cell Survival; Chelating Agents; Cyclic GMP; Dose-Response Relationship, Drug; Egtazic Acid; Endothelial Cells; Enzyme Activation; Enzyme Inhibitors; Humans; Leupeptins; Membrane Potential, Mitochondrial; Naphthoquinones; Neovascularization, Physiologic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase Type III; Oligopeptides; Signal Transduction; Time Factors | 2007 |